GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (BOM:500124) » Definitions » Gross Margin %

Dr Reddy's Laboratories (BOM:500124) Gross Margin % : 58.50% (As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Dr Reddy's Laboratories Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Dr Reddy's Laboratories's Gross Profit for the three months ended in Dec. 2023 was ₹42,203 Mil. Dr Reddy's Laboratories's Revenue for the three months ended in Dec. 2023 was ₹72,148 Mil. Therefore, Dr Reddy's Laboratories's Gross Margin % for the quarter that ended in Dec. 2023 was 58.50%.


The historical rank and industry rank for Dr Reddy's Laboratories's Gross Margin % or its related term are showing as below:

BOM:500124' s Gross Margin % Range Over the Past 10 Years
Min: 53.1   Med: 54.99   Max: 59.65
Current: 58.28


During the past 13 years, the highest Gross Margin % of Dr Reddy's Laboratories was 59.65%. The lowest was 53.10%. And the median was 54.99%.

BOM:500124's Gross Margin % is ranked better than
69.87% of 989 companies
in the Drug Manufacturers industry
Industry Median: 46.54 vs BOM:500124: 58.28

Dr Reddy's Laboratories had a gross margin of 58.50% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Dr Reddy's Laboratories was 0.60% per year.


Dr Reddy's Laboratories Gross Margin % Historical Data

The historical data trend for Dr Reddy's Laboratories's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Gross Margin % Chart

Dr Reddy's Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.23 53.84 54.33 53.10 56.67

Dr Reddy's Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.22 57.17 58.70 58.67 58.50

Competitive Comparison of Dr Reddy's Laboratories's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Reddy's Laboratories's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's Gross Margin % falls into.



Dr Reddy's Laboratories Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Dr Reddy's Laboratories's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=139343 / 245879
=(Revenue - Cost of Goods Sold) / Revenue
=(245879 - 106536) / 245879
=56.67 %

Dr Reddy's Laboratories's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=42203 / 72148
=(Revenue - Cost of Goods Sold) / Revenue
=(72148 - 29945) / 72148
=58.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Dr Reddy's Laboratories  (BOM:500124) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Dr Reddy's Laboratories had a gross margin of 58.50% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Dr Reddy's Laboratories Gross Margin % Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Reddy's Laboratories (BOM:500124) Business Description

Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories (BOM:500124) Headlines

No Headlines